#Digital Antigen Retrieval System

[genebiosolution]

Revolutionize IHC Workflows with Gene BioSolution’s Retrieval System

Bring speed, precision, and consistency to your lab with the Digital Antigen Retrieval System from Gene BioSolution. This powerful device is designed to unmask antigens effectively from formalin-fixed paraffin-embedded tissues—ensuring that your IHC results are both accurate and reproducible. Equipped with programmable settings, uniform heating technology, and safety-first operation, it’s the perfect solution for busy labs aiming to optimize their staining workflows. Whether you're conducting cancer diagnostics, antibody validation, or tissue profiling, this system delivers consistent results that meet the demands of modern pathology. Built with user-friendly features and industry-leading technology, it’s the ultimate upgrade for your histology lab.

[abbkineeu]

New Post has been published on Biotech Advisers

New Post has been published on http://www.bioadvisers.com/bioresearch-weekly/

Nanopore sequencing and assembly of a human genome with ultra-long reads

  1. IL-7 and CCL19 expression in CAR-T cells improves immune cell infiltration and CAR-T cell survival in the tumor

Infiltration, accumulation, and survival of chimeric antigen receptor T (CAR-T) cells in solid tumors is crucial for tumor clearance. Keishi Adachi at Yamaguchi University Graduate School of Medicine in Ube, Japan and his colleagues engineered CAR-T cells to express interleukin (IL)-7 and CCL19 (7 × 19 CAR-T cells), as these factors are essential for the maintenance of T-cell zones in lymphoid organs. In mice, 7 × 19 CAR-T cells achieved complete regression of pre-established solid tumors and prolonged mouse survival, with superior anti-tumor activity compared to conventional CAR-T cells. Histopathological analyses showed increased infiltration of dendritic cells (DC) and T cells into tumor tissues following 7 × 19 CAR-T cell therapy. Depletion of recipient T cells before 7 × 19 CAR-T cell administration dampened the therapeutic effects of 7 × 19 CAR-T cell treatment, suggesting that CAR-T cells and recipient immune cells collaborated to exert anti-tumor activity. Following treatment of mice with 7 × 19 CAR-T cells, both recipient conventional T cells and administered CAR-T cells generated memory responses against tumors.

Read more, please click https://www.nature.com/articles/nbt.4086

2. Random access in large-scale DNA data storage

Synthetic DNA is durable and can encode digital data with high density, making it an attractive medium for data storage. However, recovering stored data on a large-scale currently requires all the DNA in a pool to be sequenced, even if only a subset of the information needs to be extracted. Here, Lee Organick at University of Washington in Washington, USA and his colleagues encode and store 35 distinct files (over 200 MB of data), in more than 13 million DNA oligonucleotides, and show that they can recover each file individually and with no errors, using a random access approach. They design and validate a large library of primers that enable individual recovery of all files stored within the DNA. They also develop an algorithm that greatly reduces the sequencing read coverage required for error-free decoding by maximizing information from all sequence reads. These advances demonstrate a viable, large-scale system for DNA data storage and retrieval.

Read more, please click https://www.nature.com/articles/nbt.4079

3. Recon3D enables a three-dimensional view of gene variation in human metabolism

Genome-scale network reconstructions have helped uncover the molecular basis of metabolism. Here Elizabeth Brunk at University of California, San Diego in California, USA and her colleagues present Recon3D, a computational resource that includes three-dimensional (3D) metabolite and protein structure data and enables integrated analyses of metabolic functions in humans. They use Recon3D to functionally characterize mutations associated with disease, and identify metabolic response signatures that are caused by exposure to certain drugs. Recon3D represents the most comprehensive human metabolic network model to date, accounting for 3,288 open reading frames (representing 17% of functionally annotated human genes), 13,543 metabolic reactions involving 4,140 unique metabolites, and 12,890 protein structures. These data provide a unique resource for investigating molecular mechanisms of human metabolism. Recon3D is available at http://vmh.life.

Read more, please click https://www.nature.com/articles/nbt.4072

4. A DNA nanorobot functions as a cancer therapeutic in response to a molecular trigger in vivo

Nanoscale robots have potential as intelligent drug delivery systems that respond to molecular triggers. Using DNA origami Suping Li at University of Chinese Academy of Sciences in Beijing, China and his colleagues constructed an autonomous DNA robot programmed to transport payloads and present them specifically in tumors. Their nanorobot is functionalized on the outside with a DNA aptamer that binds nucleolin, a protein specifically expressed on tumor-associated endothelial cells, and the blood coagulation protease thrombin within its inner cavity. The nucleolin-targeting aptamer serves both as a targeting domain and as a molecular trigger for the mechanical opening of the DNA nanorobot. The thrombin inside is thus exposed and activates coagulation at the tumor site. Using tumor-bearing mouse models, they demonstrate that intravenously injected DNA nanorobots deliver thrombin specifically to tumor-associated blood vessels and induce intravascular thrombosis, resulting in tumor necrosis and inhibition of tumor growth. The nanorobot proved safe and immunologically inert in mice and Bama miniature pigs. Their data show that DNA nanorobots represent a promising strategy for precise drug delivery in cancer therapy.

Read more, please click https://www.nature.com/articles/nbt.4071

5. Nanopore sequencing and assembly of a human genome with ultra-long reads

Miten Jain at University of California in California, USA and his colleagues report the sequencing and assembly of a reference genome for the human GM12878 Utah/Ceph cell line using the MinION (Oxford Nanopore Technologies) nanopore sequencer. 91.2 Gb of sequence data, representing ∼30× theoretical coverage, were produced. Reference-based alignment enabled detection of large structural variants and epigenetic modifications. De novo assembly of nanopore reads alone yielded a contiguous assembly (NG50 ∼3 Mb). They developed a protocol to generate ultra-long reads (N50 > 100 kb, read lengths up to 882 kb). Incorporating an additional 5× coverage of these ultra-long reads more than doubled the assembly contiguity (NG50 ∼6.4 Mb). The final assembled genome was 2,867 million bases in size, covering 85.8% of the reference. Assembly accuracy, after incorporating complementary short-read sequencing data, exceeded 99.8%. Ultra-long reads enabled assembly and phasing of the 4-Mb major histocompatibility complex (MHC) locus in its entirety, measurement of telomere repeat length, and closure of gaps in the reference human genome assembly GRCh38.

Read more, please click https://www.nature.com/articles/nbt.4060.

[bioadvisers]

Bioadvisers shared on Biotech Advisers

Nanopore sequencing and assembly of a human genome with ultra-long reads

  1. IL-7 and CCL19 expression in CAR-T cells improves immune cell infiltration and CAR-T cell survival in the tumor

Infiltration, accumulation, and survival of chimeric antigen receptor T (CAR-T) cells in solid tumors is crucial for tumor clearance. Keishi Adachi at Yamaguchi University Graduate School of Medicine in Ube, Japan and his colleagues engineered CAR-T cells to express interleukin (IL)-7 and CCL19 (7 × 19 CAR-T cells), as these factors are essential for the maintenance of T-cell zones in lymphoid organs. In mice, 7 × 19 CAR-T cells achieved complete regression of pre-established solid tumors and prolonged mouse survival, with superior anti-tumor activity compared to conventional CAR-T cells. Histopathological analyses showed increased infiltration of dendritic cells (DC) and T cells into tumor tissues following 7 × 19 CAR-T cell therapy. Depletion of recipient T cells before 7 × 19 CAR-T cell administration dampened the therapeutic effects of 7 × 19 CAR-T cell treatment, suggesting that CAR-T cells and recipient immune cells collaborated to exert anti-tumor activity. Following treatment of mice with 7 × 19 CAR-T cells, both recipient conventional T cells and administered CAR-T cells generated memory responses against tumors.

Read more, please click https://www.nature.com/articles/nbt.4086

2. Random access in large-scale DNA data storage

Synthetic DNA is durable and can encode digital data with high density, making it an attractive medium for data storage. However, recovering stored data on a large-scale currently requires all the DNA in a pool to be sequenced, even if only a subset of the information needs to be extracted. Here, Lee Organick at University of Washington in Washington, USA and his colleagues encode and store 35 distinct files (over 200 MB of data), in more than 13 million DNA oligonucleotides, and show that they can recover each file individually and with no errors, using a random access approach. They design and validate a large library of primers that enable individual recovery of all files stored within the DNA. They also develop an algorithm that greatly reduces the sequencing read coverage required for error-free decoding by maximizing information from all sequence reads. These advances demonstrate a viable, large-scale system for DNA data storage and retrieval.

Read more, please click https://www.nature.com/articles/nbt.4079

3. Recon3D enables a three-dimensional view of gene variation in human metabolism

Genome-scale network reconstructions have helped uncover the molecular basis of metabolism. Here Elizabeth Brunk at University of California, San Diego in California, USA and her colleagues present Recon3D, a computational resource that includes three-dimensional (3D) metabolite and protein structure data and enables integrated analyses of metabolic functions in humans. They use Recon3D to functionally characterize mutations associated with disease, and identify metabolic response signatures that are caused by exposure to certain drugs. Recon3D represents the most comprehensive human metabolic network model to date, accounting for 3,288 open reading frames (representing 17% of functionally annotated human genes), 13,543 metabolic reactions involving 4,140 unique metabolites, and 12,890 protein structures. These data provide a unique resource for investigating molecular mechanisms of human metabolism. Recon3D is available at http://vmh.life.

Read more, please click https://www.nature.com/articles/nbt.4072

4. A DNA nanorobot functions as a cancer therapeutic in response to a molecular trigger in vivo

Nanoscale robots have potential as intelligent drug delivery systems that respond to molecular triggers. Using DNA origami Suping Li at University of Chinese Academy of Sciences in Beijing, China and his colleagues constructed an autonomous DNA robot programmed to transport payloads and present them specifically in tumors. Their nanorobot is functionalized on the outside with a DNA aptamer that binds nucleolin, a protein specifically expressed on tumor-associated endothelial cells, and the blood coagulation protease thrombin within its inner cavity. The nucleolin-targeting aptamer serves both as a targeting domain and as a molecular trigger for the mechanical opening of the DNA nanorobot. The thrombin inside is thus exposed and activates coagulation at the tumor site. Using tumor-bearing mouse models, they demonstrate that intravenously injected DNA nanorobots deliver thrombin specifically to tumor-associated blood vessels and induce intravascular thrombosis, resulting in tumor necrosis and inhibition of tumor growth. The nanorobot proved safe and immunologically inert in mice and Bama miniature pigs. Their data show that DNA nanorobots represent a promising strategy for precise drug delivery in cancer therapy.

Read more, please click https://www.nature.com/articles/nbt.4071

5. Nanopore sequencing and assembly of a human genome with ultra-long reads

Miten Jain at University of California in California, USA and his colleagues report the sequencing and assembly of a reference genome for the human GM12878 Utah/Ceph cell line using the MinION (Oxford Nanopore Technologies) nanopore sequencer. 91.2 Gb of sequence data, representing ∼30× theoretical coverage, were produced. Reference-based alignment enabled detection of large structural variants and epigenetic modifications. De novo assembly of nanopore reads alone yielded a contiguous assembly (NG50 ∼3 Mb). They developed a protocol to generate ultra-long reads (N50 > 100 kb, read lengths up to 882 kb). Incorporating an additional 5× coverage of these ultra-long reads more than doubled the assembly contiguity (NG50 ∼6.4 Mb). The final assembled genome was 2,867 million bases in size, covering 85.8% of the reference. Assembly accuracy, after incorporating complementary short-read sequencing data, exceeded 99.8%. Ultra-long reads enabled assembly and phasing of the 4-Mb major histocompatibility complex (MHC) locus in its entirety, measurement of telomere repeat length, and closure of gaps in the reference human genome assembly GRCh38.

Read more, please click https://www.nature.com/articles/nbt.4060.

[ihclaboratory-blog]

How PRS can help pathologist in immunohistochemistry？

Have you been looking for a product that could eliminate the false interpretations from the primary clinical diagnostics and offer a complete quality control solution for your immunohistochemical (IHC) staining?

Presenting you a product that provides a hundred per cent quality control (QC) for every single slide:

·         PRS, also known as Process Record Slide is only scientifically validated slide that has registered as Class I slide by slide calibrator in the US Food and Drug Administration (FDA).

·         Its conformal adhesive coating prevents tissue loss that occurs during the extreme conditions of HIER processing. Plus, there is an on-slide quality control for each test in order to minimize false results.

·         PRS comes with an antigen retrieval ruler that provides digital imaging baseline for pre-screening and supports best the imaging adjustment for perfect diagnosis.

·         PRS is a tool for effective decision making that assures quality and provides reliable results.

·         PRS will be available in the market from Mar 2018.

·         Successful immunohistochemistry (IHC) diagnosis starts with an effective process quality control (QC).

At present, laboratories are not able to process patient tissue samples with co-resident control materials on a single slide in accordance with the World Health Organization (WHO)'s strict requirement. In addition, laboratories have never had access to a calibrating system that can track and improve the IHC process.

But this is about to change. Process Record Slide is an innovative solution that adds quality control monitoring for the patient tissue section on a single glass slide.

FEATURES AND USES

·         IHC Staining - Get an effective record of the IHC staining experience

·         Quality Control Evaluation - Target data provides objective QC evaluation of the processing experience

·         Concentration Ruler - Target data forms the basis of an antigen concentration ruler

·         Pre-Screening - The ruler provides a digital imaging baseline for pre-screening

·         Imaging Adjustment - The ruler supports imaging adjustment so the viewing Pathologist can make the best diagnostic interpretation

·         2nd Opinion and Remote Diagnostic Opportunity - Because the record is attached to the sample, a second observer gets a complete picture of what happened in the process

APPLICATIONS ACROSS MEDICAL DISCIPLINES

The PRS technology has applications in many areas of medical research and development. At present, the Pathology QC application is the only area in medical diagnostics not covered with process controls and standards. Various uses include process control, clinical studies, and R&D testing of new drugs.

[genebiosolution]

Digital Antigen Retrieval System | Gene Bio Solution

Achieve optimal epitope exposure with our digital antigen retrieval system. Designed for fast and uniform heating of FFPE slides, it ensures consistent IHC staining results. Perfect for busy pathology labs aiming for accuracy and reproducibility.